Cardiol Therapeutics Inc. (TSX:CRDL)

Cardiol Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.58	34.93	59.47	83.9	14.03
Cash & Short-Term Investments	30.58	34.93	59.47	83.9	14.03
Cash Growth	-12.46%	-41.26%	-29.12%	498.20%	101.62%
Accounts Receivable	-	-	-	0.07	-
Other Receivables	0.36	0.28	0.48	0.34	0.22
Receivables	0.36	0.28	0.48	0.41	0.22
Inventory	-	-	-	-	0.36
Prepaid Expenses	0.73	0.94	1.49	2.83	0.35
Total Current Assets	31.67	36.15	61.44	87.14	14.95
Property, Plant & Equipment	0.2	0.34	0.3	0.36	0.48
Other Intangible Assets	-	0.21	0.29	0.38	0.46
Total Assets	31.86	36.7	62.03	87.88	15.89
Accounts Payable	6.98	7.62	8.35	4.14	1.77
Accrued Expenses	-	0.42	0.99	0.72	0.7
Current Portion of Leases	0.03	0.02	0.05	0.04	0.05
Other Current Liabilities	-	0.24	0.42	6.66	-
Total Current Liabilities	7.01	8.3	9.8	11.57	2.52
Long-Term Leases	0.13	0.16	0.02	0.07	0.1
Total Liabilities	7.14	8.45	9.83	11.64	2.62
Common Stock	179.34	148.52	147.55	142.92	51.92
Additional Paid-In Capital	24.65	18.79	15.59	12.66	8.77
Retained Earnings	-179.25	-142.58	-114.45	-83.52	-51.88
Comprehensive Income & Other	-	3.52	3.52	4.18	4.46
Shareholders' Equity	24.73	28.25	52.2	76.24	13.27
Total Liabilities & Equity	31.86	36.7	62.03	87.88	15.89
Total Debt	0.16	0.17	0.07	0.12	0.16
Net Cash (Debt)	30.42	34.76	59.4	83.78	13.87
Net Cash Growth	-12.47%	-41.48%	-29.10%	504.11%	104.99%
Net Cash Per Share	0.42	0.54	0.95	1.94	0.46
Filing Date Shares Outstanding	80.41	68.27	64.1	61.93	36.59
Total Common Shares Outstanding	80.41	65.35	64.04	61.92	32.86
Working Capital	24.66	27.86	51.63	75.58	12.43
Book Value Per Share	0.31	0.43	0.82	1.23	0.40
Tangible Book Value	24.73	28.04	51.91	75.86	12.81
Tangible Book Value Per Share	0.31	0.43	0.81	1.23	0.39
Machinery	-	0.42	0.35	0.28	0.26
Leasehold Improvements	-	0.24	0.24	0.24	0.24

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.